These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
357 related items for PubMed ID: 27085174
21. Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002. Beall B, McEllistrem MC, Gertz RE, Wedel S, Boxrud DJ, Gonzalez AL, Medina MJ, Pai R, Thompson TA, Harrison LH, McGee L, Whitney CG, Active Bacterial Core Surveillance Team. J Clin Microbiol; 2006 Mar; 44(3):999-1017. PubMed ID: 16517889 [Abstract] [Full Text] [Related]
22. Serotype distribution of invasive Streptococcus pneumoniae in Canada during the introduction of the 13-valent pneumococcal conjugate vaccine, 2010. Demczuk WH, Martin I, Griffith A, Lefebvre B, McGeer A, Shane A, Zhanel GG, Tyrrell GJ, Gilmour MW, Toronto Invasive Bacterial Diseases Network, Canadian Public Health Laboratory Network. Can J Microbiol; 2012 Aug; 58(8):1008-17. PubMed ID: 22827750 [Abstract] [Full Text] [Related]
23. Streptococcus pneumoniae genomic datasets from an Indian population describing pre-vaccine evolutionary epidemiology using a whole genome sequencing approach. Nagaraj G, Govindan V, Ganaie F, Venkatesha VT, Hawkins PA, Gladstone RA, McGee L, Breiman RF, Bentley SD, Klugman KP, Lo SW, Ravikumar KL. Microb Genom; 2021 Sep; 7(9):. PubMed ID: 34494953 [Abstract] [Full Text] [Related]
24. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait. Mokaddas E, Albert MJ. Vaccine; 2012 Dec 31; 30 Suppl 6():G37-40. PubMed ID: 23228356 [Abstract] [Full Text] [Related]
25. Impact of the Seven-valent Pneumococcal Conjugate Vaccine on Acute Otitis Media in Japanese Children: Emergence of Serotype 15A Multidrug-resistant Streptococcus pneumoniae in Middle Ear Fluid Isolates. Ozawa D, Yano H, Endo S, Hidaka H, Kakuta R, Okitsu N, Kanamori H, Ogawa M, Ichimura S, Shimojima M, Inomata S, Kaku M, Katori Y. Pediatr Infect Dis J; 2015 Sep 31; 34(9):e217-21. PubMed ID: 26083590 [Abstract] [Full Text] [Related]
26. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine. Jacobs MR, Good CE, Bajaksouzian S, Windau AR. Clin Infect Dis; 2008 Dec 01; 47(11):1388-95. PubMed ID: 18959493 [Abstract] [Full Text] [Related]
27. The effect of pneumococcal conjugate vaccines on the incidence of invasive pneumococcal disease caused by ten non-vaccine serotypes in Denmark. Slotved HC, Dalby T, Hoffmann S. Vaccine; 2016 Feb 03; 34(6):769-74. PubMed ID: 26772630 [Abstract] [Full Text] [Related]
28. Genetic analysis of invasive pneumococcal isolates from children in Ontario, Canada, 2007-2012. Deng X, Arya G, Memari N, Mackenzie R, MacMullin G, Low DE, Pillai DR, Gubbay JB. Pediatr Infect Dis J; 2015 Jun 03; 34(6):594-8. PubMed ID: 25831418 [Abstract] [Full Text] [Related]
29. Serotype distribution and antibiotic resistance among invasive Streptococcus pneumoniae from Oman post 13-valent vaccine introduction. Al-Jardani A, Al Rashdi A, Al Jaaidi A, Al Bulushi M, Al Mahrouqi S, Al-Abri S, Al-Maani A, Kumar R. Int J Infect Dis; 2019 Aug 03; 85():135-140. PubMed ID: 31150842 [Abstract] [Full Text] [Related]
30. Population structure of Streptococcus pneumoniae colonizing children before and after universal use of pneumococcal conjugate vaccines in Brazil: emergence and expansion of the MDR serotype 6C-CC386 lineage. Neves FPG, Cardoso NT, Souza ARV, Snyder RE, Marlow MM, Pinto TCA, Teixeira LM, Riley LW. J Antimicrob Chemother; 2018 May 01; 73(5):1206-1212. PubMed ID: 29401243 [Abstract] [Full Text] [Related]
31. Etiology of Acute Otitis Media and Characterization of Pneumococcal Isolates After Introduction of 13-Valent Pneumococcal Conjugate Vaccine in Japanese Children. Ubukata K, Morozumi M, Sakuma M, Takata M, Mokuno E, Tajima T, Iwata S, AOM Surveillance Study Group. Pediatr Infect Dis J; 2018 Jun 01; 37(6):598-604. PubMed ID: 29474258 [Abstract] [Full Text] [Related]
32. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005. Messina AF, Katz-Gaynor K, Barton T, Ahmad N, Ghaffar F, Rasko D, McCracken GH. Pediatr Infect Dis J; 2007 Jun 01; 26(6):461-7. PubMed ID: 17529859 [Abstract] [Full Text] [Related]
33. Changing trends in serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive diseases in Central Thailand, 2009-2012. Phongsamart W, Srifeungfung S, Chatsuwan T, Nunthapisud P, Treerauthaweeraphong V, Rungnobhakhun P, Sricharoenchai S, Chokephaibulkit K. Hum Vaccin Immunother; 2014 Jun 01; 10(7):1866-73. PubMed ID: 25424794 [Abstract] [Full Text] [Related]
34. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Farrell DJ, Klugman KP, Pichichero M. Pediatr Infect Dis J; 2007 Feb 01; 26(2):123-8. PubMed ID: 17259873 [Abstract] [Full Text] [Related]
35. Changes in molecular epidemiology of streptococcus pneumoniae causing meningitis following introduction of pneumococcal conjugate vaccination in England and Wales. Pichon B, Ladhani SN, Slack MP, Segonds-Pichon A, Andrews NJ, Waight PA, Miller E, George R. J Clin Microbiol; 2013 Mar 01; 51(3):820-7. PubMed ID: 23269742 [Abstract] [Full Text] [Related]
36. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Steens A, Bergsaker MA, Aaberge IS, Rønning K, Vestrheim DF. Vaccine; 2013 Dec 16; 31(52):6232-8. PubMed ID: 24176490 [Abstract] [Full Text] [Related]
37. Clinical and microbiological characterization of serotype 6D pneumococcal infections in South Korea. Cheong HJ, Song JY, Choi MJ, Jeon JH, Kang SH, Jeong EJ, Noh JY, Kim WJ. J Infect Chemother; 2016 Aug 16; 22(8):515-20. PubMed ID: 27234358 [Abstract] [Full Text] [Related]
38. Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden. Galanis I, Lindstrand A, Darenberg J, Browall S, Nannapaneni P, Sjöström K, Morfeldt E, Naucler P, Blennow M, Örtqvist Å, Henriques-Normark B. Eur Respir J; 2016 Apr 16; 47(4):1208-18. PubMed ID: 26797033 [Abstract] [Full Text] [Related]
39. Impact of the pneumococcal conjugate vaccine on serotype distribution of adult non-invasive Streptococcus pneumoniae isolates in Tokai region, Japan, 2008-2016. Furuya Y, Yamagishi Y, Okade H, Kadota T, Funatsu T, Eto M, Nomura N, Mitsuyama J, Mikamo H. J Infect Chemother; 2017 Jun 16; 23(6):394-399. PubMed ID: 28427991 [Abstract] [Full Text] [Related]
40. Regional differences in serotype distribution, pneumococcal vaccine coverage, and antimicrobial resistance of invasive pneumococcal disease among German federal states. Imöhl M, Reinert RR, van der Linden M. Int J Med Microbiol; 2010 Apr 16; 300(4):237-47. PubMed ID: 19604721 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]